From: MarketWatch on Fri, Jan 21 2011 7:37 PM

Executions in many states could be delayed after the lone maker of a key drug used in lethal injections has decided to permanently halt its production. WSJ’s Nathan Koppel has the latest in an interview with Simon Constable.